ALLOX
Barcelona, ES · Founded 2023 · 24 employees on LinkedIn · 1 known investors
ALLOX develops an AI-enabled platform that uses high-throughput genomics and machine learning to discover biophysical parameters governing protein function for drug discovery. The company focuses on identifying allosteric drug targets to enable development of therapies for previously undruggable proteins.
Investors · 1
Competitors · 10
by search overlap
Aulos Bioscience10 shared keywordsAulos develops an immune-activating monoclonal antibody therapeutic for cancer, using AI to design an antibody targeting the IL-2 portion that interacts with the CD25 receptor to shift IL-2 activity toward immune activation. Its lead investigational candidate, imneskibart, is in a Phase 1/2 clinical trial for solid tumor cancers including melanoma and renal cell carcinoma.
Alloy9 shared keywordsAlloy provides drug discovery services and platform technologies across genetic medicines, TCR mimics, and cell therapies, supporting pharmaceutical partners in developing novel treatments.
Allogene Therapeutics7 shared keywordsAllogene Therapeutics develops allogeneic CAR T cell therapies (AlloCAR T) for blood cancers, solid tumors, and autoimmune diseases, using off-the-shelf manufactured cell products rather than patient-derived autologous approaches. The company aims to expand CAR T treatment access through scalable manufacturing, lower costs, and faster treatment delivery.
Applied Therapeutics6 shared keywordsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.
Alx Oncology6 shared keywordsALX Oncology is a clinical-stage biopharmaceutical company developing cancer therapies, including its lead candidate evorpacept for immuno-oncology and ALX2004, an antibody-drug conjugate targeting EGFR-positive tumors. Its work focuses on novel treatments intended to extend the lives of cancer patients.
Robinhood6 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Cerecor Inc.6 shared keywordsAvalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1β antibody.
Alumis5 shared keywordsAlumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.
Bioworld5 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
StockTwits5 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Companies competing with ALLOX for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does ALLOX do?
- ALLOX develops an AI-enabled platform that uses high-throughput genomics and machine learning to discover biophysical parameters governing protein function for drug discovery. The company focuses on identifying allosteric drug targets to enable development of therapies for previously undruggable proteins.
- Who are ALLOX's investors?
- ALLOX's investors include Asabys Partners.
- Where is ALLOX headquartered?
- ALLOX is headquartered in Barcelona, ES.